Q4 2024 Earnings Call Transcript February 3, 2025 Operator: Good morning, and welcome to the IDEXX Laboratories’ Fourth ...
BofA analyst Michael Ryskin raised the firm’s price target on Idexx Laboratories (IDXX) to $535 from $475 and keeps a Neutral rating on the ...
Barclays raised the firm’s price target on Idexx Laboratories (IDXX) to $520 from $481 and keeps an Overweight rating on the shares. The ...
Investors don't like tariffs. The S&P 500 was down 1.9% in morning trading Monday, and 91% of its component stocks were down, ...
U.S. stock indexes closed lower Monday but rebounded from earlier steep losses after President Donald Trump delayed new ...
US stock indices declined at the open on Monday on worries over a full-blown trade war after President Donald Trump imposed ...
Stock indexes closed lower on Monday with tech stocks taking a hit, though partly recovering as President Trump delayed ...
Electric-vehicle maker Tesla and traditional auto manufacturers General Motors and Ford fall but claw back losses with the U.S. delaying tariffs on Mexico for a month.
IDEXX Laboratories ( IDXX) was the best-performing stock in the S&P 500 after the provider of veterinary healthcare products ...
Idexx Laboratories stock was rising sharply Monday, even as the S&P 500 and major indexes remained in the red. The Dow Jones ...
IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price ...
IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...